Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, et al
The first study to demonstrate superiority over placebo was the LEADER study, in which 9,340 patients were assigned to either liraglutide or placebo
And when youre on a GLP-1 receptor agonist, your nutritional strategy is more important than ever
Thorne sets the standard for excellence in the supplement industry
Analysts see US focused alcohol companies facing the most exposure from increased obesity medicine usage and expect a roughly 2% drop in consumption by 2035. As for GLP-1 drug users, survey data from the Brightfield Group suggests that a substantial portion are city dwellers with higher incomes that are actively engaged in exercise and diet management, while a recent survey of 2,000 US consumers from direct-to-consumer company Daily Harvest found that GLP-1 drugs were more appealing to those with self-described very healthy diets